Life sciences news
-
SimAbs secures €1 million investment for advanced antibody production
Monday September 25th 2023
Read more
-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
-
The QbD Group launches its new Business & Communications division
Monday September 18th 2023
Read more
-
AbolerIS Pharma announces €27 million in Series A financing to advance its novel treatment paradigm for autoimmune and inflammatory diseases
Sunday September 17th 2023
Read more
-
argenx announces positive CHMP opinion for subcutaneous efgartigimod for generalized myasthenia gravis
Friday September 15th 2023
Read more
-
New study discovers how neurons die in Alzheimer’s disease
Friday September 15th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development
Tuesday September 12th 2023
Read more
-
SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV
Friday September 8th 2023
Read more
-
The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain
Tuesday September 5th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
